Skip to content

Repligen Corporation Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 27, 2026 results vs estimates

Repligen Corporation · E.RGEN.NASDAQ · United States
Use symbol E.RGEN.NASDAQ in our API & Excel add-in to retrieve this data ↓
188.64
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 54.73%

Repligen Corporation Forecast

Repligen Corporation short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 54.7% a year, a typical one-standard-deviation range is 174.10–203.18 over a week, 158.84–218.44 over a month and 85.41–291.87 over a year. (Signals as of 1 Nov 2026.)

Repligen Corporation Price Chart

MacroFinance.ai

Repligen Corporation Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Repligen Corporation
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Repligen Corporation
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Repligen Corporation
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Repligen Corporation
P/S
13.24x
Mid-range vs own history
QoQ +1.3%
YoY +2.1%
now 13.24357.64 low13.69 high
ⓘP/S As of 22 Nov 2026.See Repligen Corporation returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Repligen Corporation
P/B
5.10x
Mid-range vs own history
QoQ +5.0%
YoY +15.7%
now 5.10062.77 low5.1 high
ⓘP/B As of 22 Nov 2026.See Repligen Corporation returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Repligen Corporation
EV/EBITDA
83.41x
Stretched vs own history
QoQ +43.7%
YoY +22.3%
now 83.405732.35 low83.41 high
ⓘEV/EBITDA As of 22 Nov 2026.See Repligen Corporation returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Repligen Corporation
EV/Sales
13.03x
Mid-range vs own history
QoQ +0.9%
YoY +1.1%
now 13.03167.51 low13.57 high
ⓘEV/Sales As of 22 Nov 2026.See Repligen Corporation returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Repligen Corporation
FCF Yield
1.0%
Mid-range vs own history
QoQ −7.8%
YoY −14.1%
now 0.99551 low1.79 high
ⓘFCF Yield As of 22 Nov 2026.See Repligen Corporation returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Repligen Corporation
Earnings Yield
-0.1%
Mid-range vs own history
QoQ −127.3%
YoY −684.5%
now -0.1106-0.13 low0.88 high
ⓘEarnings Yield As of 22 Nov 2026.See Repligen Corporation returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Repligen Corporation
Market Cap
$10.7B
Mid-range vs own history
QoQ +4.0%
YoY +16.2%
now 10669.10115,829 low10,747 high
ⓘMarket Cap As of 22 Nov 2026.See Repligen Corporation returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Repligen Corporation
Net Debt
-$171M
Mid-range vs own history
QoQ +42.9%
YoY +185.1%
now -170.738-170.74 low-59.88 high
ⓘNet Debt As of 22 Nov 2026.See Repligen Corporation returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Repligen Corporation
Net Debt / EBITDA
-1.36x
Low vs own history
QoQ +98.4%
YoY +203.0%
now -1.3565-1.36 low-0.43 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Repligen Corporation returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Repligen Corporation
Current Ratio
9.88x
Strong vs own history
QoQ +9.2%
YoY +18.2%
now 9.88168.36 low9.88 high
ⓘCurrent Ratio As of 22 Nov 2026.See Repligen Corporation returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Repligen Corporation
Quick Ratio
8.43x
Strong vs own history
QoQ +10.3%
YoY +18.1%
now 8.4327.12 low8.43 high
ⓘQuick Ratio As of 22 Nov 2026.See Repligen Corporation returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Repligen Corporation
Interest Coverage
0.97x
Mid-range vs own history
QoQ −29.1%
YoY +64.7%
now 0.97090.59 low1.88 high
ⓘInterest Coverage As of 22 Nov 2026.See Repligen Corporation returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Repligen Corporation
Debt / Equity
0.33x
Mid-range vs own history
QoQ +1.1%
YoY +0.1%
now 0.33090.33 low0.33 high
ⓘDebt / Equity As of 22 Nov 2026.See Repligen Corporation returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Repligen Corporation
Piotroski F-Score
6
Mid-range vs own history
QoQ −25.0%
YoY −14.3%
now 66 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Repligen Corporation returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Repligen Corporation
Altman Z-Score
8.65
Mid-range vs own history
QoQ +3.5%
YoY +16.3%
now 8.64695.23 low8.7 high
ⓘAltman Z-Score As of 22 Nov 2026.See Repligen Corporation returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  18 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Repligen Corporation, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Repligen Corporation fundamentals: income statement, balance sheet & cash flow

Repligen Corporation reported revenue of $738.3m and net income of $48.9m in FY2025, the year ended 31 December 2025 — revenue up 16.4% and net income up 291.6% on the prior year. Free cash flow was $93.9m. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$738.3m
+16.4%
Net income
$48.9m
+291.6%
Gross margin
47.09%
Free cash flow
$93.9m
-34.1%
Net debt
$123.9m
Shares short (30 Oct 2026)
7.05m
4.87 days to cover
Repligen Corporation income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue738.3634.4632.4801.5670.5
Cost of revenue390.6359.8353.9345.8279.3
Gross profit347.6274.6278.4455.7391.3
Research & development54.243.242.743.934.3
Operating income59.6-35.147.7224.7167.2
EBITDA182.580.3145.3277.3203.3
Interest expense23.222.610.03.012.7
Pre-tax income62.4-27.056.7219.1153.5
Income tax13.5-1.521.133.225.3
Net income48.9-25.535.6186.0128.3

Download Repligen Corporation fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.RGEN.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Repligen Corporation

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Repligen Corporation Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Repligen Corporation; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Repligen Corporation’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Repligen Corporation behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Repligen Corporation (United States)

Repligen Corporation is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Repligen Corporation?
Repligen Corporation is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Repligen Corporation price?
The latest close is 188.64 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Repligen Corporation in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Repligen Corporation?
20-day realised volatility is 54.7% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 15.8% over a month and 7.7% over a week.
What factors affect Repligen Corporation?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Repligen Corporation, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Repligen Corporation?
58 backtested tactical asset allocation strategies trade Repligen Corporation through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Repligen Corporation returns analysed?
The Statistical Distribution of Returns section shows the distribution of Repligen Corporation daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Repligen Corporation historical data?
In the Free historical data section of this page: the last 10 years of Repligen Corporation daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Repligen Corporation historical data (last 10 years)

Browse or instantly download the last 10 years of Repligen Corporation daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RGEN.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20163.81
2026-11-19170.29
2026-11-18172.67
2026-11-17162.18
2026-11-16162.78
2026-11-13167.79
2026-11-12166.52
2026-11-11172.62
2026-11-10173.98
2026-11-09178.94
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.